https://pharmadog.xyz/news/618351 pharmadog en 2026-10-31T11:00:00.000Z Midterm election outcomes could reshape U.S. health policy, experts say https://pharmadog.xyz/news/618307 pharmadog en 2026-10-31T10:00:28.000Z Halloween edition of Endpoints Weekly teases Anthropic biotech acquisition and Jake Van Naarden’s deal strategy https://pharmadog.xyz/news/615714 pharmadog en 2026-10-30T20:32:08.000Z FDA grants accelerated approval to first plasmid DNA immunotherapy for adult recurrent respiratory papillomatosis https://pharmadog.xyz/news/614871 pharmadog en 2026-10-30T16:16:51.000Z Sanofi plans to pursue higher European drug prices rather than delay product launches under Trump policy https://pharmadog.xyz/news/615082 pharmadog en 2026-10-30T16:16:00.000Z Vitality Works recalls 365 Whole Foods Ashwagandha capsules over possible Salmonella contamination https://pharmadog.xyz/news/614935 pharmadog en 2026-10-30T16:00:00.000Z Moderna and Merck’s individualized cancer vaccine shows promising melanoma results but shares tumble after ESMO presentation https://pharmadog.xyz/news/614703 pharmadog en 2026-10-30T15:47:13.000Z Gilead places CAR-T program on partial hold after ICANS cases; Agios delays PDUFA submission https://pharmadog.xyz/news/614728 pharmadog en 2026-10-30T15:42:22.000Z AbbVie beats Q3 expectations, lifts full-year EPS outlook as immunology and neuroscience drive growth https://pharmadog.xyz/news/614704 pharmadog en 2026-10-30T15:36:16.000Z AstraZeneca hints restructuring may trim R&D budget and move trials to emerging markets https://pharmadog.xyz/news/134233 pharmadog en 2026-10-30T15:30:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/614729 pharmadog en 2026-10-30T15:23:41.000Z AstraZeneca launches $1.5 billion cost-saving plan to fund growth, says no layoffs expected https://pharmadog.xyz/news/614730 pharmadog en 2026-10-30T15:07:04.000Z Regeneron posts $5.1 billion Q3 revenue, beating forecasts and highlighting strong sales of Dupixent, Eylea HD and Libtayo https://pharmadog.xyz/news/614731 pharmadog en 2026-10-30T15:03:13.000Z Sanofi eyes late-stage and commercial acquisitions to counter upcoming Dupixent revenue drop https://pharmadog.xyz/news/614579 pharmadog en 2026-10-30T14:45:50.000Z Vir Biotechnology appoints David Liu as chief medical officer https://pharmadog.xyz/news/614580 pharmadog en 2026-10-30T14:07:14.000Z Election stress linked to higher risk of arrhythmias and heart attacks, study finds https://pharmadog.xyz/news/614411 pharmadog en 2026-10-30T13:33:55.000Z Podcast examines Merck and Moderna’s mRNA cancer vaccine data presented at ESMO https://pharmadog.xyz/news/614412 pharmadog en 2026-10-30T13:22:49.000Z STAT+: Pharmalittle: We’re reading about AstraZeneca cost-cutting, Sun Pharma facility problems, and more https://pharmadog.xyz/news/614391 pharmadog en 2026-10-30T13:13:04.000Z Acumen scraps sole asset after Alzheimer’s fail, plunging stock 80% https://pharmadog.xyz/news/614413 pharmadog en 2026-10-30T13:12:49.000Z Lancet series highlights men’s health paradox and rising urgent-care costs https://pharmadog.xyz/news/614367 pharmadog en 2026-10-30T13:00:09.000Z Anthropic appoints former Genentech scientist Nathan Frey to lead drug discovery after acquiring Coefficient Bio https://pharmadog.xyz/news/614223 pharmadog en 2026-10-30T12:46:26.000Z Alnylam shares tumble 25% as analysts flag uncertainties in its transthyretin franchise https://pharmadog.xyz/news/614095 pharmadog en 2026-10-30T11:50:00.000Z Lilly beats forecasts and raises outlook as Novartis steadies and GSK faces investor pressure https://pharmadog.xyz/news/614031 pharmadog en 2026-10-30T11:12:36.000Z Sanofi says no major restructuring despite upcoming Dupixent patent expiration https://pharmadog.xyz/news/614032 pharmadog en 2026-10-30T11:00:55.000Z Former Be Bio chief Joanne Smith-Farrell appointed CEO of Orbis Medicines as Enanta CEO Jay Luly announces retirement https://pharmadog.xyz/news/613887 pharmadog en 2026-10-30T10:32:00.000Z Early-stage data show promise for targeting Wnt/β-catenin pathway across cancers https://pharmadog.xyz/news/613888 pharmadog en 2026-10-30T10:32:00.000Z Setara Biosciences raises $90 million Series A to advance Jazz-spun rare disease programs https://pharmadog.xyz/news/613863 pharmadog en 2026-10-30T10:30:35.000Z Setara Biosciences raises $90 million to advance rare-disease pipeline after Actio spin-out https://pharmadog.xyz/news/614264 pharmadog en 2026-10-30T10:30:00.000Z Setara Biosciences launches with $90 million to pursue Charcot-Marie-Tooth and other rare-disease therapies https://pharmadog.xyz/news/613864 pharmadog en 2026-10-30T10:00:25.000Z AI-Driven Biotech Startups May Soon Operate With Zero or One Employee, Says Endpoints News Live Discussion https://pharmadog.xyz/news/613695 pharmadog en 2026-10-30T09:49:35.000Z AstraZeneca launches $1.5 billion annual cost-saving plan to offset late-stage trial setbacks https://pharmadog.xyz/news/614342 pharmadog en 2026-10-30T09:33:00.000Z Third Rock partner’s brain cancer diagnosis highlights personal impact of biotech drug development https://pharmadog.xyz/news/613466 pharmadog en 2026-10-30T08:30:00.000Z Congress must restore independence of scientific advisory panels after controversial firings https://pharmadog.xyz/news/613465 pharmadog en 2026-10-30T08:30:00.000Z STAT reporters outline how upcoming midterms could reshape US vaccine, drug policy and the MAHA movement https://pharmadog.xyz/news/613467 pharmadog en 2026-10-30T08:30:00.000Z Patient billed $1,756 after routine urgent-care visit for UTI at Texas clinic https://pharmadog.xyz/news/613464 pharmadog en 2026-10-30T08:30:00.000Z FDA and CMS work to prevent regulatory clash as states move to test clinical AI https://pharmadog.xyz/news/613463 pharmadog en 2026-10-30T08:30:00.000Z 1834 measles letter highlights historic roots of today's anti-vaccine sentiment https://pharmadog.xyz/news/614957 pharmadog en 2026-10-30T07:43:00.000Z Bracco to invest $230M in new US contrast media plant, creating 200 jobs https://pharmadog.xyz/news/613083 pharmadog en 2026-10-30T06:11:31.000Z Aspen Neuroscience and Bambusa raise $310M combined in IPOs https://pharmadog.xyz/news/613562 pharmadog en 2026-10-30T05:04:00.000Z AstraZeneca drops two early-phase prostate cancer programs https://pharmadog.xyz/news/613394 pharmadog en 2026-10-30T04:02:00.000Z Bambusa Therapeutics exceeds IPO target raising $169 million, while Aspen Neuroscience falls short with $141 million https://pharmadog.xyz/news/615566 pharmadog en 2026-10-30T04:00:00.000Z Nova Biomedical issues safety instructions for StatStrip Glucose Hospital Meter Gen 2.0 https://pharmadog.xyz/news/615567 pharmadog en 2026-10-30T04:00:00.000Z Instrumentation Laboratories recalls several lots of HemosIL AcuStar HIT-IgG(PF4-H) assay due to false-negative risk https://pharmadog.xyz/news/613226 pharmadog en 2026-10-30T03:55:00.000Z Roche launches VENTANA BAP1 test to improve mesothelioma diagnosis https://pharmadog.xyz/news/613227 pharmadog en 2026-10-30T03:28:00.000Z Sanofi eyes 'moonshot' drug acquisitions to offset upcoming Dupixent patent loss https://pharmadog.xyz/news/613228 pharmadog en 2026-10-30T03:19:00.000Z Molecular Partners to cut up to 44% of staff as it shifts focus to radiotherapy pipeline https://pharmadog.xyz/news/612407 pharmadog en 2026-10-30T02:38:00.000Z Aspen Neuroscience raises $140M IPO to advance Parkinson’s cell therapy https://pharmadog.xyz/news/616149 pharmadog en 2026-10-30T00:00:00.000Z FDA rolls out new inspection coordination plan, lifts estradiol patch warning and HHS permits compounding of six peptides https://pharmadog.xyz/news/611686 pharmadog en 2026-10-29T21:26:00.000Z SLR Food Distribution recalls Wise Wife ground cinnamon over possible lead contamination